Invo Fertility earnings were -$7.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest IVF earnings report on Jun 30, 2026 announced Q2 2026 earnings of $888.7k, down 116% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IVF reported annual earnings of -$25.1M, with 164.3% growth.
On IVF's earnings call on Aug 13, 2026, Invo Fertility (NASDAQ: IVF) reported Q2 2026 earnings per share (EPS) of $0.42, up 100.12% year over year. Total IVF earnings for the quarter were $888.74 thousand. In the same quarter last year, Invo Fertility's earnings per share (EPS) was -$364.23.
As of the last Invo Fertility earnings report, Invo Fertility is currently losing money. Invo Fertility's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$5.29 million, a 80.01% decrease year over year.
What was IVF's earnings growth in the past year?
As of Invo Fertility's earnings date in Aug 13, 2026, Invo Fertility's earnings has grown year over year. IVF earnings in the past year totalled -$7.09 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.